EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

The Lancet Rheumatology

ISSN 2665-9913 · Elsevier BV

Latest articles

  1. Effect of ethnicity on response to treatment escalation in patients with systemic lupus erythematosus from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a longitudinal cohort study

    Sarah Dyball, Sheilla Achieng, Mia Rodziewicz, Mark Lunt, Emily Sutton, Ian N Bruce, Ben Parker, Sheilla Achieng, Yasmeen Ahmad, Mohammed Akil, Jack Arnold, Elizabeth Ball, Charlotte Barclay, Mike Batley, Michael Beresford, Anurag Bharadwaj, Ian N Bruce, Margaret Callan, Lucy Marie Carter, Matthew Cates, Antoni Chan, Alice Chieng, David D'Cruz, Shouvik Dass, Denise De Lord, Shirish Dubey, Sarah Dyball, Christopher Edwards, Mike Ehrenstein, Nicola Erb, Michelle Fernando, Mary Gayed, Patrick Gordon, Caroline Gordon, Mohini Gray, Bridget Griffiths, Nicola Gullick, Harsha Gunwardena, Shahir Hamdulay, Sahena Haque

    Published: 2026-11DOI: 10.1016/s2665-9913(26)00223-7

  2. Efficacy and safety of upadacitinib in Takayasu arteritis (SELECT-TAK): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Yoshikazu Nakaoka, Tomonori Ishii, Alexandre Wagner Silva de Souza, Sebastián Magri, Kimito Kawahata, Lindi Jiang, Haner Direskeneli, Hayato Yamazaki, Qi Yan, Weihan Zhao, Nathaniel Zerad, Aditi Kadakia, Ivan Lagunes, Arathi R Setty, Alejandro Brigante, Sebastian Magri, Alexandre de Souza, Isabella Lima, Mauro Keiserman, Lindi Jiang, Pingting Yang, Kurisu Tada, Yoshinori Matsumoto, Hiroshi Kaneko, Taishi Yonetsu, Kimito Kawahata, Hiroaki Dobashi, Shunsuke Furuta, Takeshi Ogo, Tsuyoshi Shirai, Yohei Kirino, Jun Ishizaki, Isao Matsumoto, Wataru Ishii, Koji Kinoshita, Shiro Ohshima, Rena Motohashi, Hiroaki Umebayashi, Ji Hyeon Ju, Chan-Bum Choi

    Published: 2026-11DOI: 10.1016/s2665-9913(26)00254-7

  3. The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease

    Cory A Perugino, Tobias Alexander, Matthew C Baker, Damon Brooks, Mollie N Carruthers, Bart K Chwalisz, Luke Y C Chen, Emma L Culver, Henry Danforth, Emanuel Della-Torre, Lingli Dong, Guilherme Diogo Silva, Mikael Ebbo, Hany El-Saadany, Ardeshir Falaki, Suzanne Freitag, Stacey T Gray, Phil A Hart, Sandeep S Hedgire, Yasmin Hernandez-Barco, Gabriela Hernández-Molina, Archie Hughes-Hallett, Dai Inoue, Avinash R Kambadakone, Terumi Kamisawa, Omer Karadag, Guy Katz, Mitsuhiro Kawano, Karuna Keat, Adam Kilian, Alexander Kleger, Marco Lanzillotta, Johannes-Matthias Löhr, Melis Lydston, Eduardo Martin-Nares, Fernando Martinez-Valle, Atsushi Masamune, Alireza Meysami, Paul Murphy, Shingo Nakayamada

    Published: 2026-11DOI: 10.1016/s2665-9913(26)00312-7

  4. Efficacy and safety of obinutuzumab β in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Yuhui Li, Guixiu Shi, Guoping Jiang, Min Wei, Zhichun Liu, Qiong Wu, Yingkun Nie, Rui Wu, Liyun Zhang, Hua Zhang, Jing Yang, Yinghong Liu, Shulin Song, Xiaodan Wu, Yinsuo Zheng, Li Sun, Qibing Xie, Jinjin Liang, Feng Li, Zhanguo Li, Yuhui Li, Guixiu Shi, Guoping Jiang, Min Wei, Zhichun Liu, Qiong Wu, Yingkun Nie, Rui Wu, Liyun Zhang, Hua Zhang, Jing Yang, Yinghong Liu, Shulin Song, Xiaodan Wu, Yinsuo Zheng, Li Sun, Qibing Xie, Ju Liu, Zili Fu, Kaijiang Tang

    Published: 2026-11DOI: 10.1016/s2665-9913(26)00315-2

  5. Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study

    Joerg Henes, Maria Carolina Oliveira, Myriam Labopin, Manuela Badoglio, Hans U Scherer, Nicoletta Del Papa, Thomas Daikeler, Marc Schmalzing, Roland Schroers, Thierry Martin, Gregory Pugnet, Erik W A Marijt, Gerard Espinosa, Montserrat Rovira, Raffaella Greco, Tobias Alexander, Francesco Onida, Zora Marjanovic, Dominique Farge

    Published: 2026-10DOI: 10.1016/s2665-9913(26)00227-4

  6. Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY

    Mark D Russell, Andrea Schaffer, Zijing Yang, Arti Mahto, Katie Bechman, Chris Wincup, Andrew Rutherford, Patrick Gordon, Elena Nikiphorou, Sophia Steer, Samir Patel, Kathryn Biddle, Jeremy Brown, Mark Gibson, Mrinalini Dey, Edward Alveyn, Victoria Allen, Seb Bacon, Amir Mehrkar, Brian MacKenna, Ben Goldacre, Sam Norton, Andrew P Cope, Elizabeth Price, James B Galloway

    Published: 2026-09DOI: 10.1016/s2665-9913(26)00142-6

  7. Infection risk in adults with secondary HLH

    Naina McCann, Pratyasha Saha, Melissa Chowdhury, Ranya Ramadan, Sorfina Ghazali, Sandeep Rai, Amelia Holloway, Diya Shah, Nilay Sah, Nora Kvam, Peter Shakeshaft, Preet Panesar, Robert S Heyderman, Neil R H Stone, Emilie Sanchez, Alexis Jones, Ben Carpenter, Satyen H Gohil, Michael Brown, Jessica J Manson

    Published: 2026-09DOI: 10.1016/s2665-9913(26)00224-9

  8. Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study

    Keno Bressem, Murat Torgutalp, Torsten Diekhoff, Nikolaos Kougkas, Lina Xu, Janis L Vahldiek, Xenofon Baraliakos, Hildrun Haibel, Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Judith Rademacher, Kay-Geert Hermann, Hugo J W L Aerts, Thoralf Niendorf, Thomas Keil, Stefan N Willich, Tobias Pischon, Christopher L Schlett, Steffen Ringhof, Jakob B Weiss, Fabian Bamberg, Hans-Ulrich Kauczor, Marcus R Makowski, Lisa C Adams, Andrei Zhukov, Denis Poddubnyy

    Published: 2026-08DOI: 10.1016/s2665-9913(26)00071-8

  9. Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial

    Elise van Mulligen, Quirine A Dumoulin, Hanna W van Steenbergen, Doortje I Krijbolder, A Willemien Visser, Stefan Böhringer, Annette HM van der Helm–van Mil

    Published: 2026-08DOI: 10.1016/s2665-9913(26)00109-8

Volumes

2026 · 1972025 · 2002024 · 1802023 · 1612022 · 2192021 · 2262020 · 2222019 · 61

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.